813 related articles for article (PubMed ID: 29677514)
1. Phase Separation of FUS Is Suppressed by Its Nuclear Import Receptor and Arginine Methylation.
Hofweber M; Hutten S; Bourgeois B; Spreitzer E; Niedner-Boblenz A; Schifferer M; Ruepp MD; Simons M; Niessing D; Madl T; Dormann D
Cell; 2018 Apr; 173(3):706-719.e13. PubMed ID: 29677514
[TBL] [Abstract][Full Text] [Related]
2. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites.
Yoshizawa T; Ali R; Jiou J; Fung HYJ; Burke KA; Kim SJ; Lin Y; Peeples WB; Saltzberg D; Soniat M; Baumhardt JM; Oldenbourg R; Sali A; Fawzi NL; Rosen MK; Chook YM
Cell; 2018 Apr; 173(3):693-705.e22. PubMed ID: 29677513
[TBL] [Abstract][Full Text] [Related]
3. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS.
Dormann D; Madl T; Valori CF; Bentmann E; Tahirovic S; Abou-Ajram C; Kremmer E; Ansorge O; Mackenzie IR; Neumann M; Haass C
EMBO J; 2012 Nov; 31(22):4258-75. PubMed ID: 22968170
[TBL] [Abstract][Full Text] [Related]
4. The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors.
Baade I; Hutten S; Sternburg EL; Pörschke M; Hofweber M; Dormann D; Kehlenbach RH
J Biol Chem; 2021; 296():100659. PubMed ID: 33857479
[TBL] [Abstract][Full Text] [Related]
5. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.
Guo L; Kim HJ; Wang H; Monaghan J; Freyermuth F; Sung JC; O'Donovan K; Fare CM; Diaz Z; Singh N; Zhang ZC; Coughlin M; Sweeny EA; DeSantis ME; Jackrel ME; Rodell CB; Burdick JA; King OD; Gitler AD; Lagier-Tourenne C; Pandey UB; Chook YM; Taylor JP; Shorter J
Cell; 2018 Apr; 173(3):677-692.e20. PubMed ID: 29677512
[TBL] [Abstract][Full Text] [Related]
6. Nuclear import factor transportin and arginine methyltransferase 1 modify FUS neurotoxicity in Drosophila.
Jäckel S; Summerer AK; Thömmes CM; Pan X; Voigt A; Schulz JB; Rasse TM; Dormann D; Haass C; Kahle PJ
Neurobiol Dis; 2015 Feb; 74():76-88. PubMed ID: 25447237
[TBL] [Abstract][Full Text] [Related]
7. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Suárez-Calvet M; Neumann M; Arzberger T; Abou-Ajram C; Funk E; Hartmann H; Edbauer D; Kremmer E; Göbl C; Resch M; Bourgeois B; Madl T; Reber S; Jutzi D; Ruepp MD; Mackenzie IR; Ansorge O; Dormann D; Haass C
Acta Neuropathol; 2016 Apr; 131(4):587-604. PubMed ID: 26895297
[TBL] [Abstract][Full Text] [Related]
8. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions.
Qamar S; Wang G; Randle SJ; Ruggeri FS; Varela JA; Lin JQ; Phillips EC; Miyashita A; Williams D; Ströhl F; Meadows W; Ferry R; Dardov VJ; Tartaglia GG; Farrer LA; Kaminski Schierle GS; Kaminski CF; Holt CE; Fraser PE; Schmitt-Ulms G; Klenerman D; Knowles T; Vendruscolo M; St George-Hyslop P
Cell; 2018 Apr; 173(3):720-734.e15. PubMed ID: 29677515
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of karyopherin-β2 binding and nuclear import of ALS variants FUS(P525L) and FUS(R495X).
Gonzalez A; Mannen T; Çağatay T; Fujiwara A; Matsumura H; Niesman AB; Brautigam CA; Chook YM; Yoshizawa T
Sci Rep; 2021 Feb; 11(1):3754. PubMed ID: 33580145
[TBL] [Abstract][Full Text] [Related]
10. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.
Dormann D; Rodde R; Edbauer D; Bentmann E; Fischer I; Hruscha A; Than ME; Mackenzie IR; Capell A; Schmid B; Neumann M; Haass C
EMBO J; 2010 Aug; 29(16):2841-57. PubMed ID: 20606625
[TBL] [Abstract][Full Text] [Related]
11. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions.
Troakes C; Hortobágyi T; Vance C; Al-Sarraj S; Rogelj B; Shaw CE
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):553-61. PubMed ID: 22934812
[TBL] [Abstract][Full Text] [Related]
12. Structural and energetic basis of ALS-causing mutations in the atypical proline-tyrosine nuclear localization signal of the Fused in Sarcoma protein (FUS).
Zhang ZC; Chook YM
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12017-21. PubMed ID: 22778397
[TBL] [Abstract][Full Text] [Related]
13. Impaired nuclear transport induced by juvenile ALS causing P525L mutation in NLS domain of FUS: A molecular mechanistic study.
Basu S; Rajendra KC; Alagar S; Bahadur RP
Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140766. PubMed ID: 35134572
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import.
Darovic S; Prpar Mihevc S; Župunski V; Gunčar G; Štalekar M; Lee YB; Shaw CE; Rogelj B
J Cell Sci; 2015 Nov; 128(22):4151-9. PubMed ID: 26403203
[TBL] [Abstract][Full Text] [Related]
15. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
16. A minimal construct of nuclear-import receptor Karyopherin-β2 defines the regions critical for chaperone and disaggregation activity.
Fare CM; Rhine K; Lam A; Myong S; Shorter J
J Biol Chem; 2023 Feb; 299(2):102806. PubMed ID: 36529289
[TBL] [Abstract][Full Text] [Related]
17. FUS-NLS/Transportin 1 complex structure provides insights into the nuclear targeting mechanism of FUS and the implications in ALS.
Niu C; Zhang J; Gao F; Yang L; Jia M; Zhu H; Gong W
PLoS One; 2012; 7(10):e47056. PubMed ID: 23056579
[TBL] [Abstract][Full Text] [Related]
18. R521C and R521H mutations in FUS result in weak binding with Karyopherinβ2 leading to Amyotrophic lateral sclerosis: a molecular docking and dynamics study.
Swetha RG; Ramaiah S; Anbarasu A
J Biomol Struct Dyn; 2017 Aug; 35(10):2169-2185. PubMed ID: 27381509
[TBL] [Abstract][Full Text] [Related]
19. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.
Neumann M; Bentmann E; Dormann D; Jawaid A; DeJesus-Hernandez M; Ansorge O; Roeber S; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ang LC; Bilbao J; Rademakers R; Haass C; Mackenzie IR
Brain; 2011 Sep; 134(Pt 9):2595-609. PubMed ID: 21856723
[TBL] [Abstract][Full Text] [Related]
20. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
